Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-28

Clinical Trial Update: Identification of Nerves Using Fluorescein Sodium [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by Stanford University is evaluating fluorescein sodium to help identify nerves during surgery for pleomorphic adenoma of the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluorescein Sodium (fluorescein sodium)

Snippet

Sponsor: Stanford University | Conditions: Pleomorphic Adenoma of the Parotid, Warthin Tumor | Phase 2 | Status: ENROLLING_BY_INVITATION